BAY1142524 Uses, Dosage, Side Effects and more
BAY1142524 is under investigation in clinical trial NCT02452515 (A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction).
| Trade Name | BAY1142524 |
| Generic | Fulacimstat |
| Fulacimstat Other Names | BAY1142524, Fulacimstat |
| Type | |
| Formula | C23H16F3N3O6 |
| Weight | Average: 487.391 Monoisotopic: 487.099119736 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
